Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.

Autor: van der Pol MA, Feller N, Ossenkoppele GJ, Weijers GW, Westra AH, van Stijn A, Broxterman HJ, Schuurhuis GJ
Jazyk: angličtina
Zdroj: Leukemia [Leukemia] 2003 Aug; Vol. 17 (8), pp. 1674-7.
DOI: 10.1038/sj.leu.2403025
Databáze: MEDLINE